# Smith Douglas Homes Corp.: financial statements, quarterly

SDHC · NYSE · CIK 1982518 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sdhc.md) · [Financials](/companies/sdhc/financials.md) · [Filings](/companies/sdhc/filings.md) · [Insiders](/companies/sdhc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sdhc/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [198](/filings/0001982518-24-000005.md) | [217 d](/filings/0001982518-25-000007.md) | [189](/filings/0001982518-25-000020.md) | [221](/filings/0001982518-25-000064.md) | [278](/filings/0001628280-25-049591.md) | [287 d](/filings/0001628280-26-017245.md) | [225](/filings/0001628280-26-028919.md) | [224](/filings/0001628280-26-054313.md) | [262](/filings/0001628280-25-049591.md) | [260 d](/filings/0001628280-26-017245.md) | [206](/filings/0001628280-26-028919.md) | [273](/filings/0001628280-26-054313.md) |
| Cost of revenue | $m | [141](/filings/0001982518-24-000005.md) | [159 d](/filings/0001982518-25-000007.md) | [140](/filings/0001982518-25-000020.md) | [162](/filings/0001982518-25-000064.md) | [204](/filings/0001628280-25-049591.md) | [214 d](/filings/0001628280-26-017245.md) | [171](/filings/0001628280-26-028919.md) | [172](/filings/0001628280-26-054313.md) | [207](/filings/0001628280-25-049591.md) | [209 d](/filings/0001628280-26-017245.md) | [166](/filings/0001628280-26-028919.md) | [225](/filings/0001628280-26-054313.md) |
| Gross profit | $m | [57.1](/filings/0001982518-24-000005.md) | [58.0 d](/filings/0001982518-25-000007.md) | [49.5](/filings/0001982518-25-000020.md) | [59.1](/filings/0001982518-25-000064.md) | [73.7](/filings/0001628280-25-049591.md) | [73.3 d](/filings/0001628280-26-017245.md) | [53.5](/filings/0001628280-26-028919.md) | [51.9](/filings/0001628280-26-054313.md) | [55.0](/filings/0001628280-25-049591.md) | [51.7 d](/filings/0001628280-26-017245.md) | [40.5](/filings/0001628280-26-028919.md) | [47.9](/filings/0001628280-26-054313.md) |
| Selling, general and administrative | $m | [23.0](/filings/0001982518-24-000005.md) | [27.8 d](/filings/0001982518-25-000007.md) | [27.5](/filings/0001982518-25-000020.md) | [31.8](/filings/0001982518-25-000064.md) | [34.1](/filings/0001628280-25-049591.md) | [42.9 d](/filings/0001628280-26-017245.md) | [33.0](/filings/0001628280-26-028919.md) | [34.7](/filings/0001628280-26-054313.md) | [36.1](/filings/0001628280-25-049591.md) | [36.0 d](/filings/0001628280-26-017245.md) | [35.9](/filings/0001628280-26-028919.md) | [41.9](/filings/0001628280-26-054313.md) |
| Interest expense | $m | [0.5](/filings/0001982518-24-000005.md) | [0.6 d](/filings/0001982518-25-000007.md) | [0.7](/filings/0001140361-24-026259.md) | [0.6](/filings/0001140361-24-037321.md) | [0.6](/filings/0001628280-25-049591.md) | [0.6 d](/filings/0001628280-26-017245.md) | [0.7](/filings/0001628280-26-028919.md) | [0.8](/filings/0001628280-26-054313.md) | [0.9](/filings/0001628280-25-049591.md) | [0.9 d](/filings/0001628280-26-017245.md) | [0.8](/filings/0001628280-26-028919.md) | [0.6](/filings/0001628280-26-054313.md) |
| Income tax | $m | [0.0](/filings/0001982518-24-000005.md) | [0.0 d](/filings/0001982518-25-000007.md) | [0.9](/filings/0001982518-25-000020.md) | [1.1](/filings/0001982518-25-000064.md) | [1.8](/filings/0001628280-25-049591.md) | [1.3 d](/filings/0001628280-26-017245.md) | [0.9](/filings/0001628280-26-028919.md) | [0.7](/filings/0001628280-26-054313.md) | [1.0](/filings/0001628280-25-049591.md) | [(0.1) d](/filings/0001628280-26-017245.md) | [0.3](/filings/0001628280-26-028919.md) | [0.1](/filings/0001628280-26-054313.md) |
| Net income | $m | [33.9](/filings/0001982518-24-000005.md) | [29.7 d](/filings/0001982518-25-000007.md) | [3.0](/filings/0001982518-25-000020.md) | [3.6](/filings/0001982518-25-000064.md) | [5.3](/filings/0001628280-25-049591.md) | [4.1 d](/filings/0001628280-26-017245.md) | [2.7](/filings/0001628280-26-028919.md) | [2.4](/filings/0001628280-26-054313.md) | [2.1](/filings/0001628280-25-049591.md) | [3.5 d](/filings/0001628280-26-017245.md) | [0.6](/filings/0001628280-26-028919.md) | [0.2](/filings/0001628280-26-054313.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.33](/filings/0001982518-25-000020.md) | [0.40](/filings/0001982518-25-000064.md) | [0.58](/filings/0001628280-25-049591.md) | not reported | [0.30](/filings/0001628280-26-028919.md) | [0.26](/filings/0001628280-26-054313.md) | [0.24](/filings/0001628280-25-049591.md) | not reported | [0.06](/filings/0001628280-26-028919.md) | [0.03](/filings/0001628280-26-054313.md) |
| Basic EPS | $ per share | not reported | not reported | [0.34](/filings/0001982518-25-000020.md) | [0.41](/filings/0001982518-25-000064.md) | [0.60](/filings/0001628280-25-049591.md) | not reported | [0.30](/filings/0001628280-26-028919.md) | [0.26](/filings/0001628280-26-054313.md) | [0.24](/filings/0001628280-25-049591.md) | not reported | [0.06](/filings/0001628280-26-028919.md) | [0.03](/filings/0001628280-26-054313.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [19.8](/filings/0001982518-25-000007.md) | [32.8](/filings/0001140361-24-026259.md) | [17.3](/filings/0001140361-24-037321.md) | [23.7](/filings/0001982518-24-000005.md) | [22.4](/filings/0001628280-26-017245.md) | [12.7](/filings/0001982518-25-000020.md) | [16.8](/filings/0001982518-25-000064.md) | [14.8](/filings/0001628280-25-049591.md) | [12.7](/filings/0001628280-26-054313.md) | [28.0](/filings/0001628280-26-028919.md) | [14.2](/filings/0001628280-26-054313.md) |
| Total assets | $m | not reported | [353](/filings/0001982518-25-000007.md) | [401](/filings/0001140361-24-026259.md) | [429](/filings/0001140361-24-037321.md) | [460](/filings/0001982518-24-000005.md) | [476](/filings/0001628280-26-017245.md) | [514](/filings/0001982518-25-000020.md) | [570](/filings/0001982518-25-000064.md) | [572](/filings/0001628280-25-049591.md) | [558](/filings/0001628280-26-054313.md) | [600](/filings/0001628280-26-028919.md) | [592](/filings/0001628280-26-054313.md) |
| Total liabilities | $m | not reported | [144](/filings/0001982518-25-000007.md) | [68.1](/filings/0001140361-24-026259.md) | [84.7](/filings/0001140361-24-037321.md) | [87.7](/filings/0001982518-24-000005.md) | [74.2](/filings/0001628280-26-017245.md) | [107](/filings/0001982518-25-000020.md) | [155](/filings/0001982518-25-000064.md) | [145](/filings/0001628280-25-049591.md) | [113](/filings/0001628280-26-054313.md) | [164](/filings/0001628280-26-028919.md) | [159](/filings/0001628280-26-054313.md) |
| Shareholders' equity | $m | [165](/filings/0001982518-25-000007.md) | [0.0](/filings/0001140361-24-037321.md) | [59.7](/filings/0001140361-24-026259.md) | [62.1](/filings/0001140361-24-037321.md) | [68.4](/filings/0001982518-24-000005.md) | [73.6](/filings/0001628280-26-017245.md) | [76.9](/filings/0001982518-25-000020.md) | [80.0](/filings/0001982518-25-000064.md) | [82.2](/filings/0001628280-25-049591.md) | [86.7](/filings/0001628280-26-054313.md) | [82.1](/filings/0001628280-26-028919.md) | [79.5](/filings/0001628280-26-054313.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [19.1 d](/filings/0001982518-24-000005.md) | [21.3 d](/filings/0001982518-25-000007.md) | [(9.3)](/filings/0001982518-25-000020.md) | [0.0 d](/filings/0001982518-25-000064.md) | [22.9 d](/filings/0001628280-25-049591.md) | [5.5 d](/filings/0001628280-26-017245.md) | [(34.9)](/filings/0001628280-26-028919.md) | [(28.9) d](/filings/0001628280-26-054313.md) | [22.8 d](/filings/0001628280-25-049591.md) | [9.8 d](/filings/0001628280-26-017245.md) | [0.3](/filings/0001628280-26-028919.md) | [4.5 d](/filings/0001628280-26-054313.md) |
| Capital expenditure | $m | [0.6 d](/filings/0001982518-24-000005.md) | [0.2 d](/filings/0001982518-25-000007.md) | [0.4](/filings/0001982518-25-000020.md) | [2.1 d](/filings/0001982518-25-000064.md) | [0.6 d](/filings/0001628280-25-049591.md) | [0.7 d](/filings/0001628280-26-017245.md) | [1.0](/filings/0001628280-26-028919.md) | [2.1 d](/filings/0001628280-26-054313.md) | [1.4 d](/filings/0001628280-25-049591.md) | [1.0 d](/filings/0001628280-26-017245.md) | [0.5](/filings/0001628280-26-028919.md) | [0.6 d](/filings/0001628280-26-054313.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [51.4](/filings/0001982518-25-000020.md) | [51.4](/filings/0001982518-25-000064.md) | [51.5](/filings/0001628280-25-049591.md) | [9.1](/filings/0001628280-26-028919.md) | [9.0](/filings/0001628280-26-054313.md) | [9.1](/filings/0001628280-25-049591.md) | [9.1](/filings/0001628280-26-028919.md) | [8.4](/filings/0001628280-26-054313.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.